Citigroup’s Lisata Therapeutics LSTA Stock Holding History

Citigroup’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5	Hold	1	–	–	﹤0.01%	5779
2025 Q4	$2	Buy	+1	New	+$2	﹤0.01%	5930
2024 Q3	–	Sell	-1,436	Closed	-$4.98K	–	5754
2024 Q2	$4.98K	Buy	+1,436	New	+$4.37K	﹤0.01%	5258
2022 Q3	–	Hold	0	–	–	–	6116
2022 Q2	–	Sell	-300	Closed	-$2.47K	–	6475
2022 Q1	$3K	Buy	+300	New	+$3.43K	﹤0.01%	5963
2021 Q4	–	Hold	0	–	–	–	5991
2021 Q3	–	Hold	0	–	–	–	6080
2021 Q2	–	Sell	-7	Closed	-$166	–	6282
2021 Q1	$0	Sell	7 -6	-46%	-$182	﹤0.01%	6924
2020 Q4	$0	Hold	13	–	–	﹤0.01%	7515
2020 Q3	$0	Hold	13	–	–	﹤0.01%	7534
2020 Q2	$0	Hold	13	–	–	﹤0.01%	7617
2020 Q1	$0	Hold	13	–	–	﹤0.01%	7704
2019 Q4	$1K	Hold	13	–	–	﹤0.01%	7601
2019 Q3	$1K	Hold	13	–	–	﹤0.01%	7620
2019 Q2	$0	Hold	13	–	–	﹤0.01%	7807
2019 Q1	$1K	Hold	13	–	–	﹤0.01%	7590
2018 Q4	$1K	Hold	13	–	–	﹤0.01%	7578
2018 Q3	$1K	Hold	13	–	–	﹤0.01%	7667
2018 Q2	$1K	Hold	13	–	–	﹤0.01%	7532
2018 Q1	$1K	Hold	13	–	–	﹤0.01%	7452
2017 Q4	$1K	Hold	13	–	–	﹤0.01%	7482
2017 Q3	$1K	Hold	13	–	–	﹤0.01%	7133
2017 Q2	$1K	Hold	13	–	–	﹤0.01%	7169
2017 Q1	$1K	Hold	13	–	–	﹤0.01%	7087
2016 Q4	$1K	Hold	13	–	–	﹤0.01%	7113
2016 Q3	$1K	Sell	13 -6	-32%	-$484	﹤0.01%	6984
2016 Q2	$2K	Sell	19 -1	-5%	-$92	﹤0.01%	6924
2016 Q1	$2K	Buy	20 +1	+5%	+$98	﹤0.01%	7209
2015 Q4	$3K	Hold	19	–	–	﹤0.01%	7190
2015 Q3	$4K	Hold	19	–	–	﹤0.01%	6823
2015 Q2	$5K	Sell	19 -6	-24%	-$2.23K	﹤0.01%	6754
2015 Q1	$10K	Sell	25 -20	-44%	-$10.8K	﹤0.01%	6463
2014 Q4	$26K	Buy	45 +19	+73%	+$12.9K	﹤0.01%	6088
2014 Q3	$21K	Buy	26 +5	+24%	+$4.38K	﹤0.01%	5881
2014 Q2	$21K	Buy	21 +1	+5%	+$972	﹤0.01%	5778
2014 Q1	$21K	Sell	20 -5	-20%	-$5.42K	﹤0.01%	5994
2013 Q4	$26K	Buy	+25	New	+$24.7K	﹤0.01%	6064
2013 Q3	–	Hold	0	–	–	–	6901
2013 Q2	–	Hold	0	–	–	–	6770

Other funds holding LSTA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DAM

Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citigroup's LSTA Position: Q1 2026 in Review

Citigroup held its Lisata Therapeutics (LSTA) position steady in Q1 2026 at 1 share worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #5779.

Citigroup first reported a position in LSTA in Q4 2013 and has held it in 34 quarters since. The position peaked at $26K in Q4 2014. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

Citigroup held 1 share of Lisata Therapeutics worth $5 as of Q1 2026.
Citigroup left its Lisata Therapeutics share count unchanged in Q1 2026.
Lisata Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5779 holding.
Citigroup first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 34 quarters since.
Citigroup's Lisata Therapeutics position peaked at $26K in Q4 2014.
34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.